Backs FY25 revenue view $920M-$1B, one estimate $941.62M.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on USNA:
- USNA Upcoming Earnings Report: What to Expect?
- Usana says Celavive Resurfacing Serum ‘well-tolerated’ in study
- USANA Health Sciences Faces Market Risk with Uncertain Hiya Acquisition Benefits
- USANA Health Sciences Earnings Call Highlights Growth and Strategic Moves
- USANA Health Sciences Reports 2024 Earnings and 2025 Outlook